Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
中文名称:大鼠β淀粉样蛋白1-42(Aβ1-42)酶联免疫吸附测定试剂盒
别称:
Price:
Size:
96T
48T
96T*5
- 反应性: Rat
- 检测范围: 15.63-1000 pg/mL
- 灵敏度: 9.38 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗大鼠Aβ1-42抗体包被于酶标板上,实验时样品(或标准品)中的大鼠Aβ1-42会与包被抗体结合。后依次加入生物素化的抗大鼠Aβ1-42抗体和辣根过氧化物酶标记的亲和素,抗大鼠Aβ1-42抗体与结合在包被抗体上的大鼠Aβ1-42结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,Aβ1-42浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中Aβ1-42的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Rat |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 15.63-1000 pg/mL |
灵敏度 | 9.38 pg/mL |
样本体积 | 100μL |
样本类型 | 血清,血浆,细胞上清,细胞提取液体,组织匀浆等其他生物体液 |
特异性 | 可检测样本中的大鼠Aβ1-42,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Chronic alpha-linolenic acid treatment alleviates age-associated neuropathology: Roles of PERK/eIF2α signaling pathway
IF: 7.217Journal:BRAIN BEHAVIOR AND IMMUNITY -
Targeting Aβ and p-Tau Clearance in Methamphetamine-Induced Alzheimer’s Disease-Like Pathology: Roles of Syntaxin 17 in Autophagic Degradation in Primary Hippocampal Neurons
IF: 6.543Journal:Oxidative Medicine and Cellular Longevity -
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer’s Disease Pathogenesis in Cell and Animal Models
IF: 6.035Journal:Neurotherapeutics -
Marked Response of Rat Ileal and Colonic Microbiota After the Establishment of Alzheimer's Disease Model With Bilateral Intraventricular Injection of Aβ (1-42).
IF: 5.64Journal:Frontiers in Microbiology -
Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats
IF: 5.179 -
High salt induced hypertension leads to cognitive defect
IF: 5.168Journal:Oncotarget -
Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD
IF: 4.504Journal:Frontiers in Aging Neuroscience -
Influences of periodontitis on hippocampal inflammation, oxidative stress, and apoptosis in rats
IF: 4.419 -
Qisheng Wan formula ameliorates cognitive impairment of Alzheimer's disease rat via inflammation inhibition and intestinal microbiota regulation
IF: 4.36 -
Multi-molecular Targeting
IF: 4.246Journal:Neuroscience Bulletin